Tekla Healthcare Opportunities Fund (THQ) Comparison with companies in other sectors?

Tekla Healthcare Opportunities Fund has a share price of 41.38M. You can analyze Tekla Healthcare Opportunities Fund (THQ) competitors across different market sectors through stock heatmaps.

What are THQ's NET and operating margins?

Tekla Healthcare Opportunities Fund (THQ) operating margin is around 3.09, and net profit margin is approximately 2.86 as of the latest reports.

In what way does THQ's earnings per share (EPS) trend reflect its financial momentum?

Tekla Healthcare Opportunities Fund (THQ) EPS is 0.13 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Tekla Healthcare Opportunities Fund is 118.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Tekla Healthcare Opportunities Fund?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Tekla Healthcare Opportunities Fund like P/E which is 3.33, P/B which is 0.67, and PEG which is 0.05. Compare them with sector averages to evaluate if the stock is priced fairly.

Tekla Healthcare Opportunities Fund

THQ•NYSE

Financial Services

Asset Management

$15.47

$0.21(1.38%)

Tekla Healthcare Opportunities Fund (THQ) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.13

P/E Ratio

118.00

ROE

0.20%

Net Margin

2.86%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$634.76M

Shares OutstandingTotal number of shares issued

$41.38M

Book Value/ShareNet worth per share

$22.82

Revenue/ShareAnnual revenue per share

$1.60

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.13

Net MarginNet income as percentage of revenue

286.32%

Operating MarginOperating income as percentage of revenue

308.93%

ROEReturn on shareholders' equity

20.31%

ROAReturn on total assets

16.16%

ROCEReturn on capital employed

17.44%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.09

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

0.61%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$2.16

Dividend YieldAnnual dividend as percentage of stock price

14.13%

Financial Ratios Analysis data is not available for THQFinancial Ratios Analysis details for THQ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for THQSector Benchmarking details for THQ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Tekla Healthcare Opportunities Fund Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Tekla Healthcare Opportunities Fund. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Tekla Healthcare Opportunities Fund's unique business strengths and challenges.

Key Financial Metrics for Tekla Healthcare Opportunities Fund

For Tekla Healthcare Opportunities Fund, essential financial indicators include EPS 0.13, PE 118.00, and ROE 0.20. These key ratios reveal insights into Tekla Healthcare Opportunities Fund's profitability, valuation, and operational health. Understanding these metrics enables you to compare Tekla Healthcare Opportunities Fund with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Tekla Healthcare Opportunities Fund

Metrics like Net Margin 286.32% and ROA 16.16% shed light on how well Tekla Healthcare Opportunities Fund is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Tekla Healthcare Opportunities Fund can sustain its operations and continue growing in the future.

Valuation and Market Position of Tekla Healthcare Opportunities Fund

Using ratios such as P/B Ratio 0.67 and PEG Ratio 0.05, investors can assess whether Tekla Healthcare Opportunities Fund is appropriately valued based on its financials and growth potential. These figures, combined with Tekla Healthcare Opportunities Fund's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Tekla Healthcare Opportunities Fund

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $0.09, provide a snapshot of Tekla Healthcare Opportunities Fund's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Tekla Healthcare Opportunities Fund, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Tekla Healthcare Opportunities Fund

Investing in Tekla Healthcare Opportunities Fund based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Tekla Healthcare Opportunities Fund focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;